Cargando…
CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors endangering human health and life in the 21st century. Chromatin licensing and DNA replication factor 1 (CDT1) is an important regulator of DNA replication licensing, which is essential for initiation of DNA replica...
Autores principales: | Cai, Chenhui, Zhang, Ying, Hu, Xu, Hu, Wenhui, Yang, Sizhen, Qiu, Hao, Chu, Tongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497762/ https://www.ncbi.nlm.nih.gov/pubmed/34631549 http://dx.doi.org/10.3389/fonc.2021.721644 |
Ejemplares similares
-
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021) -
Spindle and Kinetochore-associated Family Genes are Prognostic and Predictive Biomarkers in Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2022) -
BCI Suppresses RANKL-Mediated Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
por: Cai, Chenhui, et al.
Publicado: (2021) -
Incidence and Risk Factors for Adjacent Segment Disease After Transforaminal Lumbar Interbody Fusion in Patients with Lumbar Degenerative Diseases
por: Ye, Jiawen, et al.
Publicado: (2021) -
Interplay Between Iron Overload and Osteoarthritis: Clinical Significance and Cellular Mechanisms
por: Cai, Chenhui, et al.
Publicado: (2022)